Logo for Lexington Biosciences Inc.
LNB

Lexington Biosciences Inc.

Status
delisted
Issued & Outstanding3,785,340
Reserved for Issuance322,740
Currency
CSE Index

About

Lexington Biosciences Inc.

Listing Date
May 09, 2017

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.